Medikit Co.,Ltd. announces an Equity Buyback for 2,200,000 shares, representing 13.1% for ¥4,776 million.
December 05, 2023 at 01:30 am EST
Share
Medikit Co.,Ltd. (TSE:7749) announces a share repurchase program. Under the program, the company will repurchase up to 2,200,000 shares, representing 13.1% of its share capital, for ¥5,253.84 million. The shares will be repurchased at ¥2,183 per share.
The company will repurchase its shares in order to implement a flexible capital policy in response to the business environment. If the offer is oversubscribed the company may repurchase up to additional 100 shares. As of September 30, 2023, the company had 16,795,580 shares outstanding (excluding treasury shares) and 2,084,420 shares in treasury.
MEDIKIT CO., LTD. is a Japan-based company involved in the development, manufacture and sale of medical equipment. Its major products consist of artificial diagnostic equipment, which includes indwelling needles that are used for artificial dialysis purposes; indwelling venous needles (anesthesia type), which are used for blood and fluid transfusion purposes, and angiography equipment, which includes introducers and angiographic catheters.
MEDIKIT CO.,LTD. 
